A phase Ib/II multicenter open-label study of CS1001 in combination with regorafenib in patients with advanced or refractory solid tumors

  • Park, John (Primary Chief Investigator)
  • Gurney, Howard (Associate Investigator)
  • Parshionikar, Abhijit, (Clinical Trial Unit Staff)
  • Chapman, Nicola, (Clinical Trial Unit Staff)
  • Rai, Meenal, (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymCS1001/Regorafenib-101
StatusNot started